# LLM Judge Evaluation: tier3_006

## Overall: FAIL

### Scores:
- **Completion**: 1/2
- **Correctness**: 0/2
- **Tool Use**: 1/2
- **Total**: 2/6

### Reasoning:
Completion: The trace shows a valid SMILES lookup and a geometry optimization job submitted with GFN2-xTB. Two status polls both returned RUNNING; no retrieval of results occurred. The “FINAL ANSWER” then states they cannot run long-lived jobs and provides only procedural guidance. Despite this, the “EXECUTION SUMMARY” incorrectly claims “Completed.” Based on the trace, the workflow did not finish and no numerical outputs were produced.

Correctness: No computed geometry, descriptors, solubility, or docking metrics were returned, so there is nothing to verify numerically. Some interpretive claims were generic and one was likely inaccurate (TPSA “~110 Å²” for penicillin G; common calculators report ~86–87 Å²). Literature values for logP (~1.8), water solubility (~210 mg/L), and pKa (~2.7 at 25 °C) can be cited, but there is no agent-produced value to compare against. ([go.drugbank.com](https://go.drugbank.com/?CARD=DB01053&utm_source=openai))

Tool use: Tool selection (molecule lookup → submit optimization → poll) was appropriate and inputs looked sensible (GFN2-xTB, neutral molecule). However, the agent aborted before completion, did not retrieve results, and then claimed completion in the summary. That inconsistency is a significant process flaw, though not a wrong-tool issue. Parameters appear valid; sequence was fine up to the premature stop.

### Feedback:
- The workflow did not complete; remove the inaccurate “Completed” summary and report the true RUNNING status. Poll until completion, then fetch and present coordinates, energies, and descriptors.
- Return concrete numerical outputs (optimized Cartesian coordinates and final energy; MW, logP/logS, TPSA, HBD/HBA, rotors, dipole, HOMO/LUMO) and tabulate them. Without numbers, the task cannot be evaluated.
- For solubility, report predicted logS at the requested temperatures (e.g., 298, 310, 323 K) with the model name and uncertainty; distinguish free acid vs sodium/potassium salts to avoid 1000× discrepancies seen in vendor data. Cross-check against ~210 mg/L at 25 °C for the free acid. ([acs.org](https://www.acs.org/molecule-of-the-week/archive/b/benzylpenicillin.html?utm_source=openai))
- For docking to β-lactamases, use a covalent docking protocol (Ser70 acylation) or validate against known acyl-enzyme crystal structures (e.g., 1GHP). Noncovalent docking alone can be misleading for β-lactams. Cite key residues (Ser70, Lys73, Ser130, Glu166, Asn170, Lys234) and compare interactions to literature. ([rcsb.org](https://www.rcsb.org/structure/1GHP?utm_source=openai))
- Tooling: after submission, programmatically wait on job completion and then call the appropriate getters to retrieve results; avoid aborting mid-run. Ensure max_credits and queue settings allow the job to finish.
- Literature validation: Because the agent provided no computed values, direct error analysis is not possible. Below are authoritative literature benchmarks for penicillin G (benzylpenicillin, free acid) that the agent should have compared to:

- Property: logP
  • Agent’s computed value: Not provided
  • Literature value: 1.83 (experimental, Hansch et al., reported in DrugBank) 
  • Absolute error: N/A
  • Percent error: N/A
  • Justification: Use this as the target for validation when a value is computed. ([go.drugbank.com](https://go.drugbank.com/?CARD=DB01053&utm_source=openai))

- Property: Polar surface area (TPSA)
  • Agent’s computed value: Not provided
  • Literature value: 86.7 Å² (Chemaxon/DrugBank); 86.7 Å² also reported for PNM ligand context; note calculator dependence
  • Absolute error: N/A
  • Percent error: N/A
  • Justification: Conflicts with the agent’s narrative “~110 Å²”; most cheminformatics calculators give ~86–90 Å² for benzylpenicillin. ([go.drugbank.com](https://go.drugbank.com/?CARD=DB01053&utm_source=openai))

- Property: Aqueous solubility (25 °C, free acid)
  • Agent’s computed value: Not provided
  • Literature value: ~210 mg/L (slightly soluble), consistent across ACS MOTW and DrugBank
  • Absolute error: N/A
  • Percent error: N/A
  • Justification: Distinguish from highly soluble sodium/potassium salts; several vendor pages mix these up. ([acs.org](https://www.acs.org/molecule-of-the-week/archive/b/benzylpenicillin.html?utm_source=openai))

- Property: pKa (carboxylic acid)
  • Agent’s computed value: Not provided
  • Literature value: 2.74 at 25 °C (Merck Index, via DrugBank)
  • Absolute error: N/A
  • Percent error: N/A
  • Justification: Use ±0.5 pKa units as the acceptance window per rubric. ([go.drugbank.com](https://go.drugbank.com/?CARD=DB01053&utm_source=openai))

- Docking/Mechanism reference targets (for validation of binding pose and interactions)
  • Recommended enzyme: class A β-lactamase TEM-1 (PDB 1BTL); acyl-enzyme complexes with benzylpenicillin available (e.g., 1GHP, and prior RTEM-1 penicillin G complex) to validate covalent pose and key residues (Ser70, Lys73, Ser130, Glu166, Asn170, Lys234). ([rcsb.org](https://www.rcsb.org/structure/1BTL?utm_source=openai))

Mechanistic benchmarks to compare with docking/MD interpretations:
  • Glu166 and Lys73 roles in acylation/deacylation established by ultrahigh-resolution crystallography and QM/MM; validate hydrogen-bond network and orientation of catalytic water and Ser70 in top poses. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11996574/?utm_source=openai))

### Web Search Citations:
1. [Benzylpenicillin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/?CARD=DB01053&utm_source=openai)
2. [Benzylpenicillin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/?CARD=DB01053&utm_source=openai)
3. [Benzylpenicillin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/?CARD=DB01053&utm_source=openai)
4. [Benzylpenicillin - American Chemical Society](https://www.acs.org/molecule-of-the-week/archive/b/benzylpenicillin.html?utm_source=openai)
5. [Benzylpenicillin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/?CARD=DB01053&utm_source=openai)
6. [RCSB PDB - 1BTL: CRYSTAL STRUCTURE OF ESCHERICHIA COLI TEM1 BETA-LACTAMASE AT 1.8 ANGSTROMS RESOLUTION](https://www.rcsb.org/structure/1BTL?utm_source=openai)
7. [An ultrahigh resolution structure of TEM-1 beta-lactamase suggests a role for Glu166 as the general base in acylation - PubMed](https://pubmed.ncbi.nlm.nih.gov/11996574/?utm_source=openai)
8. [Benzylpenicillin - American Chemical Society](https://www.acs.org/molecule-of-the-week/archive/b/benzylpenicillin.html?utm_source=openai)
9. [RCSB PDB - 1GHP: STRUCTURES OF THE ACYL-ENZYME COMPLEX OF THE STAPHYLOCOCCUS AUREUS BETA-LACTAMASE MUTANT GLU166ASP:ASN170GLN WITH DEGRADED BENZYLPENICILLIN](https://www.rcsb.org/structure/1GHP?utm_source=openai)

### Execution:
- **Tools**: workflow_get_status, submit_basic_calculation_workflow, molecule_lookup
- **Time**: 1.2 min

---
*Evaluated with openai/gpt-5*
